"Mount Sinai Opens Biomedical Blockchain Research Center" - Bernie Monegain
The Icahn School of Medicine at Mount Sinai and the Institute for Next Generation Healthcare announced the opening of the Center for Biomedical Blockchain Research to use new technologies and data to work on healthcare and medical science problems. Joel Dudley, PhD, director of the Institute for Next Generation Healthcare at the Icahn School of Medicine at Mount Sinai and executive vice president of precision health at Mount Sinai Health System, heads the new center. Mount Sinai said the new center’s research will lay the groundwork for its forthcoming industry partnership program aimed at companies looking to develop biomedical blockchain that helps identify and address problems in clinical medicine and biomedical research. “This experience will allow us to address many of the most promising uses for blockchain in biomedicine with the goal of improving healthcare delivery and reducing costs,” said Dr. Dudley. “Our aim is to understand how blockchain and associated technologies can be applied to unmet needs in healthcare and biomedicine,” said Dr. Dudley. Dr. Dudley and his colleagues expect early use cases to emerge from areas where existing systems and approaches fall short.
- Joel Dudley, PhD, Director, Institute for Next Generation Healthcare, Associate Professor, Genetics and Genomic Sciences, Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, Executive Vice President, Precision Health, Mount Sinai Health System
- Noah H. Zimmerman, Assistant Professor, Genetics and Genomic Sciences, Director, Health Data and Design Innovation Center, Institute for Next Generation Healthcare, Icahn School of Medicine at Mount Sinai
Crain’s Health Pulse (Subscription required)